Pharmaceutical Exporter to Philippines from India
India is the Philippines' leading medicine supplier. Indian Generic Medicines (IGM) exports quality generics, oncology and specialty medicines to Philippine importers, hospitals, distributors, NGOs and pharmacies — backed by GDP-compliant logistics.
India–Philippines pharmaceutical trade
The Philippines is one of Southeast Asia's most prominent and fastest-growing pharmaceutical markets, and India is its top pharmaceutical supply partner. India was the leading source of pharmaceutical products imported by the Philippines in 2023, and Philippine imports of pharmaceutical products from India reached approximately US$443 million in 2024 — ahead of the United States.
By shipment volume, India's lead is even stronger: trade data for October 2023 to September 2024 shows India as the single largest exporter of pharmaceuticals to the Philippines, well ahead of Thailand and China. This makes Indian pharmaceutical exporters a cornerstone of the country's medicine supply chain — especially for cost-effective generic medicines.
Why India is the leading pharmaceutical exporter to the Philippines
Known as "the pharmacy of the world," India aligns closely with the Philippines' push for affordable generics through its Generics Act and Universal Health Care program.
- The world's third-largest pharmaceutical manufacturer by volume, supplying 200+ countries.
- The largest number of US FDA-approved manufacturing facilities outside the United States.
- Manufacturing under WHO-GMP, PIC/S, EU-GMP and US FDA standards.
- The world's leading generic medicine supplier — high quality at affordable prices.
Generic, oncology & specialty medicine export to the Philippines
Generic Medicine Supply
Quality-assured generics across diabetes, cardiovascular, anti-infective, respiratory, neurology and gastrointestinal categories — see our generic medicine supply.
Oncology & Specialty
Cancer therapies, targeted treatments, monoclonal antibodies and supportive care, plus hematology, neurology and rare-disease specialty therapies.
Biosimilars & Complex Generics
Cost-effective alternatives to high-value biologic therapies, subject to local registration and regulatory approval.
Availability of all medicinal products is subject to Philippine regulations, product registration status and applicable pharmaceutical requirements.
Regulatory requirements: Philippine FDA compliance
Any pharmaceutical exporter to the Philippines from India must comply with the framework administered by the Philippine Food and Drug Administration (FDA), under the Department of Health.
- License to Operate (LTO) — held by the local importer/distributor, issued by the Philippine FDA.
- Certificate of Product Registration (CPR) — each product must be registered and approved before marketing.
- GMP compliance — as a PIC/S member, the Philippines requires PIC/S-aligned Good Manufacturing Practices.
- Documentation — COA, CPP, Free Sale Certificates, COO and batch records for registration and customs.
GDP-compliant export & Named Patient Programs
GDP-Aligned Handling
Good Distribution Practice-aligned handling and storage for medicine quality and patient safety.
Cold-Chain Management
Temperature-controlled handling for biologics and oncology medicines, with shipment visibility and coordination.
Named Patient Programs
Where permitted, IGM facilitates NPP supply of unregistered oncology, specialty and rare-disease medicines for serious conditions.
Why importers in the Philippines choose Indian Generic Medicines
- Extensive global sourcing with a network of 150+ manufacturers.
- Expertise in generic, oncology and specialty medicine access.
- 12+ years of international pharmaceutical export experience.
- Export from India and Europe (Bulgaria) warehouses.
- GDP-compliant logistics and full documentation support.
- Support for importers, hospitals, pharmacies, NGOs & distributors.
Key takeaways
- India is the top pharmaceutical exporter to the Philippines, ahead of the US.
- Trade reached roughly US$385 million (2023) and about US$443 million (2024).
- Products include generics, oncology & specialty medicines, APIs and biosimilars.
- Philippine FDA registration (CPR), importer LTO and PIC/S-aligned GMP are mandatory.
- IGM offers GDP-compliant export from India with full documentation support.
- Cold-chain capability supports biologics and temperature-sensitive oncology medicines.
Frequently asked questions
Indian Generic Medicines (IGM) is an experienced Indian pharmaceutical exporter to the Philippines, supplying generic, oncology and specialty medicines to importers, wholesalers, hospitals, NGOs, pharmacies and distributors with full regulatory and documentation support.
India is the leading source of the Philippines' pharmaceutical imports, valued at approximately US$385 million in 2023 and around US$443 million in 2024, ahead of the United States.
Each product must hold a Certificate of Product Registration (CPR) from the Philippine FDA, the local importer must hold a valid License to Operate (LTO), and manufacturing must meet PIC/S-aligned GMP standards.
Yes. India is a major oncology medicine supplier for the Philippines, providing cancer therapies, biosimilars and specialty treatments, subject to Philippine FDA registration and applicable regulations.
Yes. India is the leading provider of generic medicine supply for Philippine importers, offering quality-assured, affordable formulations across major therapeutic categories.
Need a trusted pharmaceutical exporter to the Philippines?
For your hospital, pharmacy, importing business or distribution network — IGM supports product availability, transparent pricing, regulatory documentation, logistics and Philippine FDA import requirements.
References: Statista — Philippines pharmaceutical imports by source country (2023); UN COMTRADE / Trading Economics — Philippines imports from India of pharmaceutical products (2024); Philippine FDA — registration & licensing requirements; PIC/S — GMP standards; India Brand Equity Foundation (IBEF) — pharmaceutical exports from India.
